IBEC launches its Clinical Colloquia Program

As a part of IBEC’s strategy to facilitate the transfer of excellent science into health solutions for patients and hospitals, the Institute fosters relations and partnerships with clinicians and companies. Within this framework, the Institute of Bioengineering of Catalonia has now launched the IBEC Clinical Colloquia Program.

Thanks to the nature of the research developed in the institute, IBEC counts on an ongoing and committed relationship with hospitals, medical doctors and patients. As a result, the involved partners are able to develop joint research projects, and in other cases they are a source of information about the unmet needs in clinical practice. With the launching of this clinical colloquia IBEC wants to strengthen these collaborations and offer the opportunity to create a space for discussion between researchers and medical doctors.

IBEC counts on collaboration of medical doctors to provide input on the clinical aspects of its research, so that results are easily extended to clinical practice.

Read more…

Many IBEC researchers benefit from its competitive position as technological counterpart of the major hospitals in Barcelona and the international arena. IBEC’s framework agreements and collaborations with these hospitals allow easy access to clinical samples and patient information.

Moreover, IBEC works on strategic agreements with several patient associations. One example is the research agreement with the “Associació Catalana de Fibrosi Quística” which supports the work of Dr. Eduard Torrents or with the “Asociación Española Contra el Cáncer” that has provided support to the work of Nuria Montserrat, also a group leader at IBEC.

With the goal to continue and enhance these clinical collaborations, several clinical colloquiums will be held throughout the year. The first colloquium was held last November 14th at IBEC and the first speaker was Dr. Josep Pous, Medical Director at Cematec-Teknon in Barcelona and gave a talk on Theoretical and practical aspects of biophysiotherapy. “The clinical practice needs to apply the possibilities of diagnosis and treatment such as those developed at IBEC (biosensors, nanobiosensors, quantum dots) to the medical practice in order to use fewer drugs and perform fewer medical interventions” said Dr. Josep Pous. During his speech he explained the different treatment methods used in Biophysiotherapy such as Multifrequency Laser Therapy, Shock Waves, Modular Electromagnetic Waves, Mechanotherapy, Growth Factors or Stem Cells.